PF-4var/CXCL4L1 predicts outcome in stable coronary artery disease patients with preserved left ventricular function.
BACKGROUND: Platelet-derived chemokines are implicated in several aspects of vascular biology. However, for the chemokine platelet factor 4 variant (PF-4var/CXCL4L1), released by platelets during thrombosis and with different properties as compared to PF-4/CXCL4, its role in heart disease is not yet...
Main Authors: | Johan De Sutter, Nico R Van de Veire, Sofie Struyf, Jan Philippé, Marc De Buyzere, Jo Van Damme |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3285621?pdf=render |
Similar Items
-
利用核磁共振技術探討PF4/CXCL4和PF4v1/CXCL4L1的結構差異性
by: Chen, Ya-Ping, et al.
Published: (2011) -
CXCL4 and CXCL4L1 Differentially Affect Monocyte Survival and Dendritic Cell Differentiation and Phagocytosis.
by: Mieke Gouwy, et al.
Published: (2016-01-01) -
Reduced CXCL4/PF4 expression as a driver of increased human hematopoietic stem and progenitor cell proliferation in polycythemia vera
by: Fabienne Meier-Abt, et al.
Published: (2021-02-01) -
The Role of Post-Translational Modifications of Chemokines by CD26 in Cancer
by: Alexandra De Zutter, et al.
Published: (2021-08-01) -
Structural and functional correlation of CXCL4 and CXCL4L1 chemokines
by: Chen, Ya-Ping, et al.
Published: (2018)